41 results
8-K
EX-10.1
SMTI
Sanara MedTech Inc
5 Apr 24
Departure of Directors or Certain Officers
9:15am
and/or prospective client, referral source, business partner, investor, supplier, distributor, contractor, merchant and/or vendor lists, databases, identity
8-K
EX-99.1
SMTI
Sanara MedTech Inc
13 Nov 23
Sanara MedTech Inc. Announces Third Quarter 2023 Results
4:42pm
and tissue-based product. First sales of Allocyte Plus occurred in early October 2023. This product is processed by an alternative supplier with in-house … in the third quarter of 2023. However, subsequent to the end of the quarter, the Company brought on an alternative supplier and expanded the ALLOCYTE®
8-K
EX-10.1
SMTI
Sanara MedTech Inc
2 Aug 23
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
9:20am
, supplier information, personnel matters and records, and matters that are sensitive, business related, proprietary and confidential in nature.
Page 4 … , he shall not, directly or indirectly, induce or attempt to induce any customer or supplier or anyone else having business with the Company to breach
8-K
EX-2.1
xx5ep8hmiv1680iym
5 Jul 22
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
9:20am
8-K
EX-10.1
hbi dyncpncod
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-10.2
4nzkf5qv
29 Apr 22
Departure of Directors or Certain Officers
8:25am
8-K
EX-2.1
b0xnuv6
4 Apr 22
Entry into a Material Definitive Agreement
6:34am
8-K
EX-10.1
ooqaq
19 Jul 21
Sanara MedTech Inc. Announces the Purchase of Certain Assets from Rochal Industries, LLC
4:47pm
8-K
EX-1.1
xwyuq
17 Feb 21
Sanara MedTech Inc. Announces Proposed Public Offering of Common Stock
4:29pm
424B5
moi7c bja9v
16 Feb 21
Prospectus supplement for primary offering
4:52pm
424B5
mby e8mqu
11 Feb 21
Prospectus supplement for primary offering
4:06pm